Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging - Jerusalem, G; Beguin, Y; Fassotte, M F (Blood, 1999)
et al.